๐”– Scriptorium
โœฆ   LIBER   โœฆ
๐Ÿ“

Antiarrhythmic Drugs

โœ Scribed by Antoni Martรญnez-Rubio, Juan Tamargo, Gheorghe- Andrei Dan

Publisher
Springer International Publishing;Springer
Year
2020
Tongue
English
Leaves
433
Series
Current Cardiovascular Therapy
Edition
1st ed.
Category
Library
โฌ‡  Acquire This Volume

No coin nor oath required. For personal study only.

โœฆ Synopsis

This volume reviews current and potential future therapies for arrhythmias. It is a highly practical guide for the use of pharmaceuticals in the management of the discipline, and has been written in a simple quick-access format.

Antiarrhythmic Drugs builds on the current understanding of pathophysiological mechanisms and insights gained from previous studies of therapeutic interventions. It is designed to establish the baseline level of knowledge that a cardiovascular professional needs to know on a day-to-day basis.

โœฆ Table of Contents

Front Matter ....Pages i-viii
Mechanisms of Cardiac Arrhythmias (Teresa Barrio-Lopez, Jesรบs Almendral)....Pages 1-29
Class I Antiarrhythmic Drugs: Na+ Channel Blockers (Mohammad Shenasa, Mohammad-Ali Shenasa, Mariah Smith)....Pages 31-105
Class III Antiarrhythmic Drugs (Juan Tamargo, Ricardo Caballero, Eva Delpรณn)....Pages 107-180
Beta-blockers as Antiarrhythmic Agents (Catalin Adrian Buzea, Anca Rodica Dan, Gheorghe-Andrei Dan)....Pages 181-231
Modulation of Calcium Handling: Calcium-Channel Modulators (Erol Tรผlรผmen, Martin Borggrefe)....Pages 233-264
Other Antiarrhythmic Drugs (Juan Tamargo)....Pages 265-306
Antiarrhythmic Properties of Non-Antiarrhythmic Drugs in Atrial Fibrillation: Upstream Therapy (Alina Scridon, Antoni Martรญnez-Rubio)....Pages 307-377
Clinical Significance and Management of Arrhythmias (Antoni Martรญnez-Rubio, Gheorghe-Andrei Dan)....Pages 379-422
Back Matter ....Pages 423-428

โœฆ Subjects

Medicine & Public Health; Cardiology; Pharmacology/Toxicology; Pharmacotherapy

๐Ÿ“œ SIMILAR VOLUMES

Antiarrhythmic Drugs
๐Ÿ“ Antiarrhythmic Drugs
โœ E. M. Vaughan Williams (auth.), E. M. Vaughan Williams Professor Dr. (eds.) ๐Ÿ“‚ Library ๐Ÿ“… 1989 ๐Ÿ› Springer-Verlag Berlin Heidelberg ๐ŸŒ English

<p>The development of a new antiarrhythmic drug involves many people with disparate skills. The organic chemist who makes it is guided not only by the structure-action relations of previous compounds, but by anticipation of a requirement for a particular type of action. In fact several of the best-k

Antiarrhythmic Drugs
๐Ÿ“ Antiarrhythmic Drugs
โœ Antoni Martรญnez-Rubio; Juan Tamargo; Gheorghe-Andrei Dan ๐Ÿ“‚ Library ๐Ÿ“… 2020 ๐Ÿ› Springer International Publishing ๐ŸŒ English
Antiarrhythmic Drugs: Mechanisms of Anti
๐Ÿ“ Antiarrhythmic Drugs: Mechanisms of Antiarrhythmic and Proarrhythmic Actions
โœ A. O. Grant (auth.), Prof. Dr. med. Gรผnter Breithardt, Priv.-Doz. Dr. Martin Bor ๐Ÿ“‚ Library ๐Ÿ“… 1995 ๐Ÿ› Springer-Verlag Berlin Heidelberg ๐ŸŒ English

<p>Management and prevention of tachyarrhythmias, especially of serious ventricular arrhythmias after myocardial infarction, is still a major problem. Large-scale evidence suggests an increased harm induced by antiarrhythmic drugs in the presence of organic heart disease although they effectively su

Novel Therapeutic Targets for Antiarrhyt
๐Ÿ“ Novel Therapeutic Targets for Antiarrhythmic Drugs
โœ George Edward Billman ๐Ÿ“‚ Library ๐Ÿ“… 2010 ๐Ÿ› Wiley ๐ŸŒ English

<b>Profiles potential treatment approaches for cardiac arrhythmias <p> Cardiac arrhythmias of ventricular origin are responsible for the deaths of nearly half a million Americans each year while atrial fibrillation accounts for about 2.3 million cases per year, a rate that is projected to inc

Novel Therapeutic Targets for Antiarrhyt
๐Ÿ“ Novel Therapeutic Targets for Antiarrhythmic Drugs
โœ George Edward Billman ๐Ÿ“‚ Library ๐Ÿ“… 2010 ๐ŸŒ English

Profiles potential treatment approaches for cardiac arrhythmiasCardiac arrhythmias of ventricular origin are responsible for the deaths of nearly half a million Americans each year while atrial fibrillation accounts for about 2.3 million cases per year, a rate that is projected to increase 2.5 fold